Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 89.65% | 79.03% | -35.65% | -84.47% | 21.20% |
| Total Depreciation and Amortization | 6.88% | -14.24% | 4.00% | 6.65% | 121.86% |
| Total Amortization of Deferred Charges | -2.35% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.37% | 104.45% | -58.81% | -0.04% | 110.70% |
| Change in Net Operating Assets | -134.31% | -154.93% | 343.79% | 86.34% | -85.63% |
| Cash from Operations | 0.84% | -45.25% | 64.77% | -36.75% | 190.65% |
| Capital Expenditure | 13.78% | 68.54% | -13.08% | -1,652.22% | 69.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | 13.78% | 77.03% | -54.87% | -1,652.22% | 69.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.14% | 75.77% | -312.69% | 0.00% | 0.00% |
| Issuance of Common Stock | 1,124.62% | -- | -- | -- | -- |
| Repurchase of Common Stock | -62.32% | -93.73% | 58.85% | -651.14% | 72.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -28.82% | 17.62% | -312.50% | 10.92% | 45.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.60% | 341.06% | -170.25% | -92.26% | 164.34% |
